(IN BRIEF) IQ Biozoom, a medical technology startup, is developing non-invasive home diagnostics that allow people to measure the concentration of biochemical substances in liquid analytes like saliva, sweat, urine, or tears. Their technology integrates inkjet printing with advanced semiconductors, … Read the full press release
Posted in Business, Healthcare, Investment, Pharma & Biotech, Poland, Small Business, Technology
Tagged biomarker, biosensor system, blood glucose, blood glucose meters, Diabetes, endocrine disorders, glucose, glucose monitoring, home diagnostics, home tests, IQ Biozoom, lactate levels, medical technology, medical technology startup, medtech, metabolic disorders, non-invasive home diagnostics, non-invasive home testing, personalised medicine, saliva analysis, sports medicine, startup, VC Link fund
Innovation Center project of Merck aims to develop smart neurostimulators for targeted treatment of chronic diseases Second collaboration within the Bioelectronics innovation field of Merck focuses on increasing the selectivity and power efficiency of the device to enable energy intensive … Read the full press release
Posted in Germany, Healthcare, News, Pharma & Biotech, Science, Spain, Technology
Tagged bioelectronic, bioelectronic therapies, bioelectronics, Bioelectronics innovation, Carolina Aguilar, chronic diseases, electronic therapies, endocrine disorders, graphene, graphene electrodes, graphene interfaces, Inbrain Neuroelectronics, inflammatory disorders, Innervia Bioelectronics, Jurriaan Baker, Laura Matz, Merck, metabolic disorders, neuroloop GmbH, neurostimulators, physiological datasets, precise signal coding, Reduced Graphene Oxide, rGO, Robert Spoelgen, selective neurostimulation, start-up, vagus nerve
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
